4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-22-008416
Options or other derivatives
- Chief Financial Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Chardonnet Laurent Chief Financial Officer | 2022-12-21 | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | D | ||
Loading xslF345X03/primarydocument.xml…